Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

The logrank test.

Bland JM, Altman DG.

BMJ. 2004 May 1;328(7447):1073. Review. No abstract available.

2.
3.

An asymptotic analysis of the logrank test.

Strawderman RL.

Lifetime Data Anal. 1997;3(3):225-49.

4.

Preoperative anaplastic glioma tumor volume effects on patient survival.

Xue D, Albright RE Jr.

J Surg Oncol. 1999 Dec;72(4):199-205.

PMID:
10589034
5.

Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.

Prados MD, Scott CB, Rotman M, Rubin P, Murray K, Sause W, Asbell S, Comis R, Curran W, Nelson J, Davis RL, Levin VA, Lamborn K, Phillips TL.

Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):653-9.

PMID:
9486616
7.

A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.

McKeever PE, Ross DA, Strawderman MS, Brunberg JA, Greenberg HS, Junck L.

J Neuropathol Exp Neurol. 1997 Jul;56(7):798-805.

PMID:
9210876
8.

Survival of children with infratentorial neuroglial tumors. The Childhood Brain Tumor Consortium.

Sobel EL, Gilles FH, Leviton A, Tavaré CJ, Hedley-Whyte ET, Rorke LB, Adelman LS.

Neurosurgery. 1996 Jul;39(1):45-54; discussion 54-6.

PMID:
8805139
9.
10.

[Accelerated hyperfractionation in the treatment of malignant glioma].

Sugawara T, Nakazawa M, Mizutani Y, Hyodoh H.

Nihon Igaku Hoshasen Gakkai Zasshi. 1994 Mar 25;54(4):278-85. Japanese.

PMID:
8177703
11.

On the analysis of life tables for dependent observations.

Aalen OO.

Stat Med. 1994 Nov 30;13(22):2383-4. No abstract available.

PMID:
7855471
12.

Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survival.

Puduvalli VK, Kyritsis AP, Hess KR, Bondy ML, Fuller GN, Kouraklis GP, Levin VA, Bruner JM.

Int J Oncol. 2000 Nov;17(5):963-9.

PMID:
11029499
13.

Prognostic value of perfusion MR imaging of high-grade astrocytomas: long-term follow-up study.

Hirai T, Murakami R, Nakamura H, Kitajima M, Fukuoka H, Sasao A, Akter M, Hayashida Y, Toya R, Oya N, Awai K, Iyama K, Kuratsu JI, Yamashita Y.

AJNR Am J Neuroradiol. 2008 Sep;29(8):1505-10. doi: 10.3174/ajnr.A1121. Epub 2008 Jun 12.

14.
15.

A partially grouped logrank test.

Sposto R, Stablein D, Carter-Campbell S.

Stat Med. 1997 Mar 30;16(6):695-704.

PMID:
9131757
16.

Proton MR spectroscopy provides relevant prognostic information in high-grade astrocytomas.

Majós C, Bruna J, Julià-Sapé M, Cos M, Camins A, Gil M, Acebes JJ, Aguilera C, Arús C.

AJNR Am J Neuroradiol. 2011 Jan;32(1):74-80. doi: 10.3174/ajnr.A2251. Epub 2010 Oct 28.

17.

Reoperation for glioma.

Berger MS, Tucker A, Spence A, Winn HR.

Clin Neurosurg. 1992;39:172-86. Review. No abstract available.

PMID:
1333931
18.

Recent developments in survival analysis.

Andersen PK.

Stat Methods Med Res. 2010 Feb;19(1):3-4. doi: 10.1177/0962280209105018. No abstract available.

PMID:
20139135
19.

Hyperfractionated radiotherapy for brain stem tumours in children.

Skowrońska-Gardas A.

Radiother Oncol. 1994 Dec;33(3):259-61.

PMID:
7716266
20.

Fast neutron therapy for malignant gliomas--results from NIRS study. National Institute of Radiological Sciences.

Mizoe JE, Aoki Y, Morita S, Tsunemoto H.

Strahlenther Onkol. 1993 Apr;169(4):222-7.

PMID:
8387697

Supplemental Content

Support Center